We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App





New Patented Technology Determines Who Should Receive COVID-19 Vaccine First by Tracing Coronavirus “Super Distributors”

By HospiMedica International staff writers
Posted on 23 Sep 2020
Print article
Illustration
Illustration
A new technology aims to determine which people should be first given the COVID-19 vaccine before the rest of the population to effectively stop the spread of the SARS-CoV-2 virus.

The technology developed by the Ehrlich Group (Ramat-Gan, Israel) was recently filed for a patent in the United Arab Emirates’ patent office, according to a report by the Jerusalem Post. The long-awaited COVID-19 vaccine is just months away from potentially curing the world from the SARS-CoV-2 virus, although it would take years to manufacture, distribute and vaccinate the entire world population.

Using data about the number of contacts and interactions by each individual, the new patented technology will establish priority guidelines for the vaccination of the population against COVID-19. The technology will trace "super-distributors” of the SARS-CoV-2 virus who will be given priority for administering the COVID-19 vaccine. The technology is based on the analysis of data collected from Israeli intelligence agencies or from various apps where users approve the use of their location data. By tracing and vaccinating super distributors of the SARS-CoV-2 virus, the chains of transmissions and infections within the community can be broken, making it possible to stop the spread of the SARS-CoV-2 virus even before the entire population is vaccinated, thus saving time and money, according to the Jerusalem Post report.

Related Links:
Ehrlich Group

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Breast Imaging Workstation
SecurView

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.